The FDA expects companies to perform meaningful, results driven Design Control activities as defined in the CFR, for both new and changed devices. The company is held fully responsible for deciding when to start and the specific documentation to meet the 9 requirements. Beyond compliance, these 9 elements can be a powerful tool in reducing "time to market" - "fast cycle" product development.
For More Information Contact -
Organization: NetZealous BDA GlobalCompliancePanel
Website: www.globalcompl...
Email: support@globalcompliancepanel.com
Help us caption & translate this video!
amara.org/v/LJLB/
21 окт 2024
